Metraipolis › archive › dc_61510d98c080

Inhibition of HER2 signaling and breast cancer cell growth with a novel antibody targeting HER2 ECD III/IV — Europe PMC PMID:41538393

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41538393
DOI: 10.1371/journal.pone.0338127
License (as archived): solo-consultazione
Archived: 2026-11-06T19:16:05.833Z
SHA-256 of the archived text: 84214937c9845ff99eb00ef3f60f2750dd8a5ca311322a70435ad0dc078a0409
Stable URL of this page: https://metraipolis.com/documento/dc_61510d98c080

How to cite

Inhibition of HER2 signaling and breast cancer cell growth with a novel antibody targeting HER2 ECD III/IV — Europe PMC PMID:41538393 — Europe PMC (en), https://europepmc.org/article/MED/41538393 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_61510d98c080 (Metraipolis archive dc_61510d98c080, sha256 84214937c9845ff99eb00ef3f60f2750dd8a5ca311322a70435ad0dc078a0409)

BibTeX

@misc{dc61510d98c080,
  title = {Inhibition of HER2 signaling and breast cancer cell growth with a novel antibody targeting HER2 ECD III/IV — Europe PMC PMID:41538393},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41538393},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_61510d98c080; sha256 84214937c9845ff99eb00ef3f60f2750dd8a5ca311322a70435ad0dc078a0409},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41538393. Agents can read the archived copy with the MCP tool read_document.